Safety is the paramount concern of Canadian Blood Services. Because blood is a biopharmaceutical product, it must be manufactured with the same strict regulatory standards as any drug, using Good Manufacturing Practices (GMP) standards.
As a result of Canadian Blood Services' commitment to meeting national and international safety standards, Canada’s blood supply is recognized as one of the safest in the world.
Canadian Blood Services carefully screens all prospective donors to minimize the potential for transmission of infectious diseases. Donated blood undergoes extensive testing for infectious diseases, and blood groups and compatibility.
Surveillance Report 2013